TCL Archive Patient Advocacy: Survivorship Programs Win Funds To form Model Programs December 13, 1996
TCL Archive Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2 April 17, 1987